CLYM
Climb Bio Inc
11.90$
-5.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -127.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -23.7% | +3.4% | +26.7% | -13.2% | – | |
| – | +83.2% | -61.3% | +10.1% | +470.7% | -43.3% | +22.0% | -49.9% | +292.5% | -73.8% | +53.9% | -7.7% | – | |
| – | -81.0% | -145.0% | – | -166.4% | – | +135.1% | -176.6% | – | – | -263.7% | – | – | |
| – | – | – | – | – | – | – | – | +41.6% | -100.0% | – | – | – | |
| – | +31.1% | -62.6% | -170.1% | +644.3% | -25.6% | -20.0% | – | +218.8% | +67.4% | -150.7% | +342.0% | – | |
| – | -45.5% | -94.8% | +855,913.3% | -98.2% | -98.2% | -100.0% | – | – | – | – | +2,073,960.0% | – | |
| – | +11.5% | -66.7% | +890.9% | -165.2% | – | – | – | – | +216.6% | -376.6% | – | – | |
| – | -127.1% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.